BioLife Solutions, Inc. (BLFS) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $21.30 (+1.04%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 24, 2025 | Yi Chen | H.C. Wainwright | $32.00 | +50.2% |
| Nov 15, 2024 | Jacob Johnson | Stephens | $30.00 | +40.8% |
| Aug 12, 2024 | Matt Hewitt | Craig-Hallum | $30.00 | +40.8% |
| Apr 4, 2024 | Matthew Stanton | Jefferies | $22.00 | +3.3% |
Top Analysts Covering BLFS
BLFS vs Sector & Market
| Metric | BLFS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +54.9% | +1150.2% | +14.9% |
| P/E Ratio | -82.28 | 6.94 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $112M | $113M | $114M | 7 |
| 2027-03-31 | $30M | $30M | $31M | 4 |
| 2027-06-30 | $32M | $32M | $33M | 3 |
| 2027-09-30 | $34M | $35M | $35M | 3 |
| 2027-12-31 | $36M | $36M | $37M | 3 |
| 2028-03-31 | $38M | $38M | $39M | 2 |
| 2028-06-30 | $39M | $40M | $40M | 5 |
| 2028-09-30 | $42M | $43M | $44M | 4 |
| 2028-12-31 | $44M | $45M | $45M | 4 |
| 2029-12-31 | $196M | $199M | $203M | 1 |
| 2030-12-31 | $235M | $239M | $243M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.08 | $0.15 | $0.21 | 3 |
| 2027-03-31 | $0.07 | $0.07 | $0.07 | 1 |
| 2027-06-30 | $0.08 | $0.08 | $0.08 | 1 |
| 2027-09-30 | $0.09 | $0.09 | $0.10 | 1 |
| 2027-12-31 | $0.10 | $0.10 | $0.10 | 1 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 1 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 1 |
| 2029-12-31 | $1.28 | $1.31 | $1.34 | 1 |
| 2030-12-31 | $1.77 | $1.81 | $1.85 | 1 |
Frequently Asked Questions
What is the analyst consensus for BLFS?
The consensus among 2 analysts covering BioLife Solutions, Inc. (BLFS) is Buy with an average price target of $33.00.
What is the highest price target for BLFS?
The highest price target for BLFS is $32.00, set by Yi Chen at H.C. Wainwright on 2025-11-24.
What is the lowest price target for BLFS?
The lowest price target for BLFS is $22.00, set by Matthew Stanton at Jefferies on 2024-04-04.
How many analysts cover BLFS?
2 analysts have issued ratings for BioLife Solutions, Inc. in the past 12 months.
Is BLFS a buy or sell right now?
Based on 2 analyst ratings, BLFS has a consensus rating of Buy (2.00/5) with a +54.9% upside to the consensus target of $33.00.
What are the earnings estimates for BLFS?
Analysts estimate BLFS will report EPS of $0.15 for the period ending 2026-12-31, with revenue estimated at $113M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.